摘要
活性氧和活性氮加重老年人的内皮功能障碍,并导致心血管疾病的发展,例如动脉粥样硬化、糖尿病和高血压。1951年,α-硫辛酸被认为是一种促进丙酮酸和α-酮戊二酸氧化脱羧的催化剂,从而受到了化学家、生物学家和临床医师的深入研究,这些专家们对它在能量代谢中的作用和防止活性氧诱发的线粒体功能障碍的作用感兴趣。因此,α-硫辛酸补充剂的许多生物学效用可能由α-硫辛酸和二氢α-硫辛酸强有力的抗氧化性能引起。细胞内部的还原环境能有助于防止氧化损伤,α-硫辛酸的氧化还原状态取决于处在氧化状态下的细胞组件的氧化程度。尽管健康的年轻人可以合成足够的α-硫辛酸来清除活性氧和增强内源性抗氧化剂如谷胱甘肽和维生素C和E,α-硫辛酸的水平随着年龄的增长而显著降低,这可能导致内皮功能障碍。此外,许多研究报道了α-硫辛酸能调节与抗氧化和抗炎途径相关的基因的转录。这篇综述,我们将讨论最近关于探索α-硫辛酸在血管内皮功能障碍方面的有益作用的临床研究,并提出可能的参与机制。
关键词: α-酮酸脱氢酶复合物,心血管疾病,内皮功能障碍,谷胱甘肽,甘氨酸裂解酶,活性氧,巯基二硫键,硫氧还蛋白
Current Medicinal Chemistry
Title:Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Volume: 21 Issue: 32
Author(s): Sungmi Park, Udayakumar Karunakaran, Nam Ho Jeoung, Jae-Han Jeon and In-Kyu Lee
Affiliation:
关键词: α-酮酸脱氢酶复合物,心血管疾病,内皮功能障碍,谷胱甘肽,甘氨酸裂解酶,活性氧,巯基二硫键,硫氧还蛋白
摘要: Reactive oxygen species and reactive nitrogen species promote endothelial dysfunction in old ageand contribute to the development of cardiovascular diseases such as atherosclerosis, diabetes, and hypertension. α-lipoic acid was identified as a catalytic agent for oxidative decarboxylation of pyruvate and α-ketoglutarate in 1951, and it has been studied intensively by chemists, biologists, and clinicians who have been interested in its role in energetic metabolism and protection from reactive oxygen species-induced mitochondrial dysfunction. Consequently, many biological effects of α- lipoic acid supplementation can be attributed to the potent antioxidant properties of α-lipoic acid and dihydro α-lipoic acid. The reducing environments inside the cell help to protect from oxidative damage and the reduction-oxidation status of α-lipoic acid is dependent upon the degree to which the cellular components are found in the oxidized state. Although healthy young humans can synthesize enough α-lipoic acid to scavenge reactive oxygen species and enhance endogenous antioxidants like glutathione and vitamins C and E, the level of α-lipoic acid significantly declines with age and this may lead to endothelial dysfunction. Furthermore, many studies have reported α-lipoic acid can regulate the transcription of genes associated with anti-oxidant and anti-inflammatory pathways. In this review, we will discuss recent clinical studies that have investigated the beneficial effects of α-lipoic acid on endothelial dysfunction and propose possible mechanisms involved.
Export Options
About this article
Cite this article as:
Park Sungmi, Karunakaran Udayakumar, Jeoung Ho Nam, Jeon Jae-Han and Lee In-Kyu, Physiological Effect and Therapeutic Application of Alpha Lipoic Acid, Current Medicinal Chemistry 2014; 21 (32) . https://dx.doi.org/10.2174/0929867321666140706141806
DOI https://dx.doi.org/10.2174/0929867321666140706141806 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reversing Agents for ATP-Binding Cassette (ABC) Transporters: Application in Modulating Multidrug Resistance (MDR)
Current Medicinal Chemistry - Anti-Cancer Agents Myoglobin as a New Fluorescence Probe to Sense H2S
Protein & Peptide Letters Prevention and Management of Hypertension Without Drugs
Current Hypertension Reviews The Predictive Value of Vessel-Based Calcium Score in the Detection of Coronary Stenosis
Current Medical Imaging Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design PREFACE: “The Lower the Better” Association between White-coat Effect-excluded Blood Pressure and Cardiovascular Events in High-risk Hypertension: Insights from SPRINT
Current Hypertension Reviews Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Current Drug Targets Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus
Current Diabetes Reviews Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?
Current Vascular Pharmacology Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors
Current Clinical Pharmacology The Renin-Angiotensin System: Emerging Concepts
Current Hypertension Reviews Determination of Residual Solvents in Eprosartan Mesylate by Static Headspace Gas Chromatographic Method Optimized by Response Surface Methodology
Current Pharmaceutical Analysis Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Infant Breast-Feeding and Suppression of Biomarkers of Future Cardiovascular Disease
Current Nutrition & Food Science Contemporary Risk Assessment and Cardiovascular Outcomes in Peripheral Arterial Disease
Cardiovascular & Hematological Disorders-Drug Targets Recent Advancement and Technological Aspects of Pulsatile Drug Delivery System - A Laconic Review
Current Drug Targets The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Cardiovascular Effects of Green Tea Catechins: Progress and Promise
Recent Patents on Cardiovascular Drug Discovery